Prevalence of and Risk Factors for Hepatitis B Viremia After Spontaneous Hepatitis B Surface Antigen Seroclearance in Hepatitis B Carriers

Chia-Ming Chu; Yun-Fan Liaw
January 2012
Clinical Infectious Diseases;1/1/2012, Vol. 54 Issue 1, p88
Academic Journal
In 118 previous hepatitis B surface antigen (HBsAg) carriers, low-level hepatitis B (HBV) viremia persisted at a rate of 15%-20% for >10 years after HBsAg seroclearance. The frequency of HBV viremia was significantly (P = .002) lower in patients with anti-HBsAg seroconversion (6 of 69 [8.7%]) than in those without seroconversion (15 of 49 [30.6%]).


Related Articles

  • People with Multiple Tattoos and/or Piercings Are Not at Increased Risk for HBV or HCV in The Netherlands. Urbanus, Anouk T.; Van den Hoek, Anneke; Boonstra, Albert; Van Houdt, Robin; De Bruijn, Lotte J.; Heijman, Titia; Coutinho, Roel A.; Prins, Maria // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Background: Although published results are inconsistent, it has been suggested that tattooing and piercing are risk factors for HBV and HCV infections. To examine whether tattooing and piercing do indeed increase the risk of infection, we conducted a study among people with multiple tattoos...

  • Hepatitis B Infection in Microbiology Laboratory Workers: Prevalence, Vaccination, and Immunity Status. Jha, Arun Kumar; Chadha, Sanjim; Bhalla, Preena; Saini, Sanjeev // Hepatitis Research & Treatment;2012, p1 

    The risk of contracting HBV by health care workers (HCW) is four-times greater than that of general adult population. Studies have demonstrated that vaccine-induced protection persists at least 11 years. High risk groups such as HCWs should be monitored and receive a booster vaccination if their...

  • Comparative Effectiveness Research of Chronic Hepatitis B and C Cohort Study (CHeCS): Improving Data Collection and Cohort Identification. Lu, Mei; Rupp, Loralee; Moorman, Anne; Li, Jia; Zhang, Talan; Lamerato, Lois; Holmberg, Scott; Spradling, Philip; Teshale, Eyasu; Vijayadeva, Vinutha; Boscarino, Joseph; Schmidt, Mark; Nerenz, David; Gordon, Stuart // Digestive Diseases & Sciences;Dec2014, Vol. 59 Issue 12, p3053 

    Background and Aims: The Chronic Hepatitis Cohort Study (CHeCS) is a longitudinal observational study of risks and benefits of treatments and care in patients with chronic hepatitis B (HBV) and C (HCV) infection from four US health systems. We hypothesized that comparative effectiveness...

  • DIFICULT TO TREAT PATIENTS WITH HBeAg NEGATIVE CHRONIC B HEPATITIS. Curescu, Manuela // Therapeutics, Pharmacology & Clinical Toxicology;2009, Vol. 13 Issue 4, p397 

    Background. There are 2 billion people infected worldwide, with approximately 5% of the world's population (or 350 million people) being carriers of chronic hepatitis B. [2] Worldwide, chronic hepatitis B is the 10th leading cause of death. HBeAg-negative chronic hepatitis B patients show a...

  • Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy. Crane, Megan; Avihingsanon, Anchalee; Rajasuriar, Reena; Velayudham, Pushparaj; Iser, David; Solomon, Ajantha; Sebolao, Baotuti; Tran, Andrew; Spelman, Tim; Matthews, Gail; Cameron, Paul; Tangkijvanich, Pisit; Dore, Gregory J.; Ruxrungtham, Kiat; Lewin, Sharon R. // Journal of Infectious Diseases;Sep2014, Vol. 210 Issue 5, p745 

    We investigated the relationship between microbial translocation, immune activation, and liver disease in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) coinfection. Lipopolysaccharide (LPS), soluble CD14, CXCL10, and CCL-2 levels were elevated in patients with HIV/HBV coinfection....

  • Conceptos Recientes Acerca de la Hepatitis B. Reyes Romero, Heberto; Navarro Rojas, Pedro; Romero González, Vanessa; Yáñez Gónzalez, Rosabella; Reyes Barrios, Heberto; de la Parte, María A. // Informe Medico;2014, Vol. 16 Issue 1, p10 

    B virus hepatitis (BVH) is an international public health problem produced by an hepadnavirus (hepadviridae family) with double DNA strands organized in a 20 nm nucleocapside, surrounded by an external cover that release the surface antigen HBsAg. Epidemiology: More than 2,000 million people...

  • Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. Paul, Sonali; Saxena, Akriti; Terrin, Norma; Viveiros, Kathleen; Balk, Ethan M.; Wong, John B. // Annals of Internal Medicine;1/5/2016, Vol. 164 Issue 1, p30 

    Background: Solid tumor chemotherapy regimens pose a risk for hepatitis B virus (HBV) reactivation, but screening and antiviral prophylaxis remains controversial because of insufficient evidence.Purpose: To determine the risk for HBV reactivation with and without...

  • Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection. Mya, D. H. T.; Han, S. T.; Linn, Y. C.; Hwang, W. Y. K.; Goh, Y. T.; Tan, D. C. L. // Annals of Oncology;Feb2012, Vol. 23 Issue 2, p421 

    Background: The purpose of the study is to analyse the prevalence of hepatitis B virus (HBV) infection and its incidence of reactivation among multiple myeloma (MM) patients treated in the era of novel therapy in an endemic Asian setting. Patients and methods: From 2000 to 2008, 273 patients...

  • Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey. Salem, Fatemeh; Hekmat, Soheila; Aghasadeghi, Mohammad Reza; Javadi, Foozieh; Gholami, Hossein; Mostafavi, Ehsan // Jundishapur Journal of Microbiology;Aug2013, Vol. 6 Issue 6, p1 

    Objectives: The aim of the present study was to determine the rate, risk factors and genotypes of Hepatitis B virus amongst imprisoned men as a high-risk subpopulation. Patients and Methods: This study was an anonymous cross-sectional study conducted on 3000 sentenced men in Karaj jails from 1...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics